Athersys (ATHX) Competitors

Eyenovia (NASDAQ:EYEN) and Athersys (NASDAQ:ATHX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Which has stronger valuation and earnings, EYEN or ATHX?

Eyenovia has higher earnings, but lower revenue than Athersys. Eyenovia is trading at a lower price-to-earnings ratio than Athersys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eyenovia	$57.34K	87.36	-$27.26M	-$58.40	-0.03
Athersys	$146K	0.00	-$72.53M	-$2.03	N/A

Is EYEN or ATHX more profitable?

Athersys has a net margin of 0.00% compared to Eyenovia's net margin of -114,639.41%. Athersys' return on equity of 0.00% beat Eyenovia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eyenovia	-114,639.41%	-1,108.24%	-139.36%
Athersys	N/A	N/A	-223.03%

Does the media favor EYEN or ATHX?

In the previous week, Eyenovia had 6 more articles in the media than Athersys. MarketBeat recorded 7 mentions for Eyenovia and 1 mentions for Athersys. Eyenovia's average media sentiment score of 0.84 beat Athersys' score of 0.00 indicating that Eyenovia is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Eyenovia	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Athersys	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility and risk, EYEN or ATHX?

Eyenovia has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500. Comparatively, Athersys has a beta of -0.9, suggesting that its share price is 190% less volatile than the S&P 500.

Does the MarketBeat Community prefer EYEN or ATHX?

Athersys received 191 more outperform votes than Eyenovia when rated by MarketBeat users. However, 64.21% of users gave Eyenovia an outperform vote while only 56.15% of users gave Athersys an outperform vote.

Company	Underperform	Outperform
Eyenovia	Outperform Votes 174 64.21%	Underperform Votes 97 35.79%
Athersys	Outperform Votes 365 56.15%	Underperform Votes 285 43.85%

Do insiders and institutionals hold more shares of EYEN or ATHX?

25.8% of Eyenovia shares are held by institutional investors. Comparatively, 19.4% of Athersys shares are held by institutional investors. 7.1% of Eyenovia shares are held by company insiders. Comparatively, 0.0% of Athersys shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Do analysts rate EYEN or ATHX?

Eyenovia currently has a consensus price target of $2.00, suggesting a potential upside of 12.99%. Given Eyenovia's stronger consensus rating and higher probable upside, equities research analysts clearly believe Eyenovia is more favorable than Athersys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eyenovia	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Athersys	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Eyenovia beats Athersys on 10 of the 16 factors compared between the two stocks.